Government initiatives to disseminate information about the chronic disease of snoring, by organizing health awareness campaigns, increase the rate of diagnosis of patients. The gradual growth in the number of patients suffering from snoring opens up a lucrative atmosphere for market players to experiment with technologies and produce user-friendly solutions.
Given the wide availability of advanced solutions, there is a rapid evolution from inhaling essential oils to anti-snoring devices. Anti-snoring devices are the primary treatment for the condition, with more advanced cases being treated with surgery. Based on ingenious insights obtained through exhaustive research, Fact.MR study predicts stable growth prospects for the anti-snoring devices and snoring surgery market with a collective value of approximately $20 billion. dollars by 2020.
Discover the performance of the Europe region for anti-snoring devices and snoring surgery market – https://www.factmr.com/connectus/sample?flag=S&rep_id=4322
Key Takeaways from Anti-Snoring Devices and Snoring Surgery Market Research
- The over-the-counter availability of anti-snoring devices gives them a high sales potential compared to prescribed devices. The relatively easy FDA approvals for these devices and the growing trend of online shopping will, in turn, amplify the penetration of anti-snoring products globally.
- Uvulopalatopharyngoplasty (UPPP) surgery is expected to remain the surgery of choice during the forecast period (2020-2025), estimated to account for around 41% of the total revenue generated in 2020. However, the recent past has witnessed a rapid increase in the number of outpatient centers offering snoring care. This, coupled with patients seeking minimally invasive surgeries, is expected to increase the adoption of radiofrequency ablation (RFA) surgery over the period 2020-2025.
- Manufacturers are increasingly focusing on developing relatively less invasive products. Additionally, efficacy and portability are expected to remain a focus of R&D activities undertaken by anti-snoring devices and snoring surgery market players.
- Health insurance companies are now including anti-snoring devices and snoring surgery in their insurance coverage, further increasing their adoption. For example, Medicare worked with ResMed Inc. to reimburse a 3-month trial of CPAP therapy for patients diagnosed with sleep apnea.
Share your needs and get personalized reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4322
“The growing number of sleep labs for treating acute sleep apnea and other sleep disorders creates an extremely conducive environment for the market. As awareness of these labs increases, these are expected to become a crucial sales channel for market players”says a subject matter expert at Fact.MR.
Forward Integration – Key Strategy for Market Players
The market for anti-snoring devices and snoring surgery is highly fragmented. Market players at different levels are focusing on product differentiation by introducing compact neoteric devices, especially wireless devices. For example, Provent – a key player in the market – has integrated Bluetooth technology to develop a disposable, compact, battery-operated CPAP device that can be placed over the nostrils to treat snoring. Another action plan for players is forward integration by strengthening distribution networks in key markets with high ROI potential, such as China and Germany.
Find more valuable insights into Anti Snoring Devices and Snoring Surgery Market
Fact.MR, in its new offering, highlights an unbiased analysis of the global anti-snoring devices and snoring surgery market, showcasing historical demand data (2014-2019) and forecast statistics for the period 2020 -2025. The study discloses compelling insights into the anti-snoring devices and snoring surgery market based on the devices (mandibular advancement devices (MADs), tongue stabilization devices (TSDs), positive pressure devices continuous (CPAP) and others (nasal and chin advancement devices (bands, straps, rings, etc.)) and surgical intervention (tonsillectomy and adenoidectomy surgery, uvulopalatopharyngoplasty surgery (UPPP), surgery of maxillomandibular and genioglossus advancement, abutment procedure with palatal implant surgery, radiofrequency ablation (RFA) surgery and others (eg, laser-assisted uvulopalatoplasty, tracheostomy, etc.)), in five major regions.
About Fact.MR Health Division
Fact.MR’s healthcare team helps clients with unique business intelligence needs globally. With a repository of over 1,000 reports and over a million data points, the team has analyzed the health sector at a micro level in over 50 countries for more than a decade. The team provides end-to-end research and advisory services to help clients stay on top. Contact us to find out how we can help you.
Buy now for exclusive analyst support – https://www.factmr.com/checkout/4322/S
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide spectrum – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.
USA Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
The head office:
Unit number: AU-01-H (AU) gold tower,
Parcel number: JLT-PH1-I3A,
Jumeirah Lakes Tours,
Dubai, United Arab Emirates